Nitin Madhukar Kamble, DO | |
400 Northwood Dr, Centre, AL 35960-1023 | |
(256) 927-4900 | |
Not Available |
Full Name | Nitin Madhukar Kamble |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 23 Years |
Location | 400 Northwood Dr, Centre, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811214737 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
New research from The University of Texas Health Science Center at Houston School of Public Health, released Tuesday in Alcoholism: Clinical & Experimental Research, shows that higher levels of drinking among United States-Mexico border young adults are closely linked to their patterns of bar attendance, but not to how they think about drinking.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
During his research, carried out at the NUP/UPNA-Public University of Navarre, he conducted five studies on 361 participants: four on male football players between the ages of 10 and 17, one on distance and middle-distance runners, adult men and women.
"The head of the U.N. mission in Haiti Edmond Mulet unveiled new efforts Tuesday to provide secure housing to thousands of people made homeless by January's devastating earthquake," Agence France-Presse reports.
› Verified 3 days ago
Entity Name | Medstar Medical Group Ii Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
New research from The University of Texas Health Science Center at Houston School of Public Health, released Tuesday in Alcoholism: Clinical & Experimental Research, shows that higher levels of drinking among United States-Mexico border young adults are closely linked to their patterns of bar attendance, but not to how they think about drinking.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
During his research, carried out at the NUP/UPNA-Public University of Navarre, he conducted five studies on 361 participants: four on male football players between the ages of 10 and 17, one on distance and middle-distance runners, adult men and women.
"The head of the U.N. mission in Haiti Edmond Mulet unveiled new efforts Tuesday to provide secure housing to thousands of people made homeless by January's devastating earthquake," Agence France-Presse reports.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Nitin Madhukar Kamble, DO Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Nitin Madhukar Kamble, DO 400 Northwood Dr, Centre, AL 35960-1023 Ph: (256) 927-4900 |
News Archive
New research from The University of Texas Health Science Center at Houston School of Public Health, released Tuesday in Alcoholism: Clinical & Experimental Research, shows that higher levels of drinking among United States-Mexico border young adults are closely linked to their patterns of bar attendance, but not to how they think about drinking.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
During his research, carried out at the NUP/UPNA-Public University of Navarre, he conducted five studies on 361 participants: four on male football players between the ages of 10 and 17, one on distance and middle-distance runners, adult men and women.
"The head of the U.N. mission in Haiti Edmond Mulet unveiled new efforts Tuesday to provide secure housing to thousands of people made homeless by January's devastating earthquake," Agence France-Presse reports.
› Verified 3 days ago
James Christian Lamousin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Brian Patrick Quigley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Dwayne Narayan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Michelle Williams Schofield, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Stephen Solomon Hurwitz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Andrew Gerritt Smith, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 | |
Anna Teal Steffan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Northwood Dr, Centre, AL 35960 Phone: 256-927-4900 |